Gregory Moss
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Gregory S.
Moss is currently Director at Vitls, Inc., Independent Director at Anteris Technologies Global Corp.
starting in 2025, Member of the New York State Bar Association, Member of the New South Wales Bar Association, and Secretary, Chief Compliance & Business Officer at Evommune, Inc. since 2022.
Formerly, Mr. Moss was Director at MeiraGTx Holdings Plc from 2018 to 2019, Secretary, Chief Compliance Officer & EVP at Kadmon Holdings, Inc. from 2012 to 2022, and General Counsel & Compliance Officer at MeiraGTx Ltd. from 2015 to 2016.
Education includes undergraduate and graduate degrees from Macquarie University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EVOMMUNE, INC. 0.18% | 28.05.2026 | 64’010 ( 0.18% ) | 1 Mio $ | 31.05.2026 |
0.02% | 07.06.2026 | 17’580 ( 0.02% ) | 151 540 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| EVOMMUNE, INC. | Compliance Officer | 01.06.2022 |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Corporate Officer/Principal | - |
New South Wales Bar Association | Corporate Officer/Principal | - |
Vitls, Inc.
Vitls, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops wearable medical devices for homes and hospitals | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| KADMON HOLDINGS, INC. | Compliance Officer | 01.06.2022 |
| MEIRAGTX HOLDINGS PLC | Direktor/Vorstandsmitglied | 19.06.2019 |
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders | Compliance Officer | 01.12.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Kadmon Holdings, Inc.
Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Macquarie University
Macquarie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
New South Wales Bar Association | Government |
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders | Health Technology |
MeiraGTx Holdings Plc
MeiraGTx Holdings Plc BiotechnologyHealth Technology Develops and manufactures genetic medicines | Health Technology |
Vitls, Inc.
Vitls, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops wearable medical devices for homes and hospitals | Electronic Technology |
Evommune, Inc.
Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen